Avid Radiopharmaceuticals
Latest round
- Series D
Last raised
- May 2009
Total raised
- $70M
Investors
- 8
About Avid Radiopharmaceuticals
Avid Radiopharmaceuticals is dedicated to developing innovative PET imaging agents for neurodegenerative disease diagnostics. The company was acquired in November 2010 by Eli Lilly for USD 800 mn. Its headquarters is located in Philadelphia, US, and the company has conducted five deals to date, with its most recent deal occurring on November 8, 2010.Avid Radiopharmaceuticals specializes in the development of advanced diagnostic solutions aimed at improving patient outcomes through early disease diagnosis and monitoring treatment effects. The company’s core product offerings include Amyvid, launched in 2012, and Tauvid, introduced in 2020, both FDA-approved PET imaging agents designed to identify amyloid plaques and tau proteins associated with neurodegenerative diseases.Avid Radiopharmaceuticals generates revenue through the sales of its diagnostic imaging agents, Amyvid and Tauvid, to healthcare institutions and providers. Transactions are conducted through direct sales to hospitals and clinics, integrating these diagnostic tools into routine clinical practice.Following its acquisition by Eli Lilly in 2010, Avid Radiopharmaceuticals plans to leverage its resources for the development of new diagnostic products aimed at further enhancing its portfolio in neurodegenerative disease diagnostics. The company is also looking to expand into new markets, including additional healthcare providers in Europe and North America.
Who invested in Avid Radiopharmaceuticals
8 investors across 4 rounds
See all investors in Avid Radiopharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Avid Radiopharmaceuticals
Who invested in Avid Radiopharmaceuticals?
Avid Radiopharmaceuticals has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avid Radiopharmaceuticals raised?
Avid Radiopharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Avid Radiopharmaceuticals last raise money?
Avid Radiopharmaceuticals's most recent round on record is a Series D, in May 2009.
What does Avid Radiopharmaceuticals do?
Avid Radiopharmaceuticals is dedicated to developing innovative PET imaging agents for neurodegenerative disease diagnostics.
Where is Avid Radiopharmaceuticals headquartered?
Avid Radiopharmaceuticals is headquartered in Philadelphia, US.
Which VCs invest in companies like Avid Radiopharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Avid Radiopharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Avid Radiopharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.